Pacific Biosciences of California (PACB)
Healthcare
Medical Devices
1.40 $
+1.4%
vs. previous close
Closing price · As of: 3. Aug 2026
Pacific Biosciences of California (PACB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -111 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -51 | -48 | -68 | -68 | -66 | -78 | 20 | -111 | -263 | -267 | -206 | -111 | |
| 4.2 | 3.7 | 3.9 | 8.4 | 7.2 | 9.9 | 9.3 | 12 | 17 | 33 | 53 | 386 | |
| 9.9 | 14 | 20 | 20 | 23 | 16 | 18 | 81 | 79 | 72 | 71 | 42 | |
| 10 | 14 | 19 | 21 | 23 | -1.4 | -16 | 37 | 87 | – | – | – | |
| -0.8 | -31 | -18 | -6.0 | 5.7 | -3.0 | -2.8 | 21 | -54 | -59 | -41 | 4.4 | |
| 1.6 | 3.0 | 8.2 | 10 | 1.9 | 2.8 | 1.0 | 5.9 | 17 | 8.8 | 6.2 | 2.7 | |
| 20 | 8.6 | -15 | -1.5 | -38 | 62 | -219 | -679 | 116 | 4.6 | 124 | 115 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| 42 | 36 | 66 | 73 | 107 | 8.5 | 234 | 327 | – | – | – | – | |
| -4.5 | -4.5 | -4.5 | -4.5 | -16 | -16 | -16 | 895 | -1.6 | -1.8 | -0.5 | 0.0 | |
| 42 | 36 | 66 | 69 | 107 | 27 | 252 | 1,170 | 9.6 | 116 | -43 | 3.4 | |
| 10 | -2.8 | -17 | -0.3 | 2.3 | 10 | 52 | 380 | -138 | -145 | -124 | 7.7 | |
| -53 | -51 | -76 | -78 | -68 | -81 | 18 | -117 | -280 | -275 | -212 | -114 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.